Mingxi Wan Selected Research

Mingxi Wan Research Topics

Disease

21	Neoplasms (Cancer) 12/2023 - 01/2008
6	Breast Neoplasms (Breast Cancer) 12/2022 - 09/2007
2	Neoplasm Metastasis (Metastasis) 10/2023 - 06/2019
2	Hypertension (High Blood Pressure) 01/2023 - 11/2020
2	Necrosis 01/2022 - 07/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2015 - 06/2010
1	Hyperthermia 07/2022
1	Glioma (Gliomas) 07/2022
1	Brain Neoplasms (Brain Tumor) 06/2022
1	Thrombosis (Thrombus) 01/2022
1	Hematoma 01/2020
1	Hemorrhage 06/2019
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2016
1	Atherosclerosis 07/2016
1	Shock 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2015
1	Osteosarcoma (Osteogenic Sarcoma) 06/2012
1	Carcinogenesis 10/2008

Drug/Important Bio-Agent (IBA)

4	Therapeutic UsesIBA 07/2022 - 06/2012
3	ElementsIBA 12/2023 - 01/2016
3	LipidsIBA 01/2023 - 10/2020
2	PolymersIBA 01/2023 - 10/2021
2	Hyaluronic Acid (Hyaluronan)IBA 12/2022 - 06/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 05/2019
2	perfluoropentane (perflenapent)IBA 10/2021 - 10/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 06/2010 - 10/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 10/2008 - 09/2007
1	CytokinesIBA 12/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Adenosine Triphosphate (ATP)IBA 07/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 07/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	ferric oxide (iron oxide)IBA 10/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Protein Subunits (Protein Subunit)IBA 01/2020
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2017
1	Nerve Growth Factor (NGF)IBA 12/2016
1	Bovine Serum AlbuminIBA 01/2016
1	polyacrylamideIBA 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2015
1	Peptides (Polypeptides)IBA 10/2015
1	contrast agent BR1IBA 10/2015
1	Mitochondrial Permeability Transition PoreIBA 10/2015
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2015
1	methylene diphosphonateIBA 06/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012
1	Liposomes (Liposome)IBA 06/2012
1	Salmonella O-specific polysaccharide (SOSP)IBA 06/2012
1	thiazolyl blueIBA 06/2012
1	Heme Oxygenase-1IBA 06/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2010
1	sodium carbonate FDA LinkGeneric 10/2008
1	Phosphates (Orthophosphate)IBA 10/2008
1	BuffersIBA 10/2008
1	Indicators and Reagents (Reagents)IBA 09/2007

Therapy/Procedure

19	Therapeutics 10/2023 - 01/2008
7	Microbubbles 10/2023 - 10/2015
3	Immunotherapy 10/2023 - 07/2022
2	Aftercare (After-Treatment) 12/2023 - 07/2022
2	Precision Medicine 10/2021 - 01/2021
1	Photothermal Therapy 01/2021
1	Intravenous Administration 10/2020
1	Catheters 06/2019
1	Ultrasonic Therapy 07/2016